# US 2006/0052337 A1 · Polysaccharide and composition from Antrodia camphorata and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0052337 A1
- Document ID: US20060052337A1
- Status: Published application
- Kind: A1
- Application number: 11/203,410
- Filed: 2005-08-15
- Published: 2006-03-09
- Earliest claimed: 2004-08-17
- Assignees: Simpson Biotech Co., Ltd.
- Inventors: Masao Hattori; Chia-Chin Sheu
- Web page: https://patentgrep.com/patent/US20060052337A1

## CPC

- C07D 207/444: having two doubly-bound oxygen atoms directly attached in positions 2 and 5
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C07D 207/46: with hetero atoms directly attached to the ring nitrogen atom
- C07D 307/34: having two or three double bonds between ring members or between ring members and non-ring members
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention relates to polysaccharide extracted from Antrodia camphorata and the method for preparing the polysaccharide. The invention also relates to compositions and methods for hepatoprotective effect.

## Claims

### Claim 1

A polysaccharide extracted from Antrodia camphorata having characteristics as follows:
(a) appearance: colorless and shapeless powder,
(b) pH: neutral,
(c) molecular weight: 1285 kDa determined by HPLC as shown in FIG. 4,
(d) rotatory power: [α]D+115.0° (c=0.4433, H2O),
(e) intrinsic viscosity: [η]=0.0417 dl·g−1,
(f) specific heat Cp: 0.2663 Cal/g·° C.,
(g) IR spectrum: as shown in FIG. 5,
(h) 1H-NMR spectrum: as shown in FIG. 6,
(i) 13C-NMR spectrum: as shown in FIG. 7, and
(j) GC-MS analysis: as shown in FIG. 8.

### Claim 2 (depends on 1)

The polysaccharide as claimed in claim 1, wherein the IR spectrum shows the component sugars comprising galactose, glucose, fucose, mannose and galatosamine.

### Claim 3 (depends on 2)

The polysaccharide as claimed in claim 2, wherein the 1H-NMR spectrum further shows the component sugars comprising D-galactose, D-glucose, L-fucose and D-mannose.

### Claim 4 (depends on 3)

The polysaccharide as claimed in claim 3, wherein the ratio of the component sugars comprising galactose, glucose, fucose, mannose and galatosamine is 1:0.46:0.035:0.016:0.092.

### Claim 5 (depends on 4)

The polysaccharide as claimed in claim 4, wherein the component sugars have main chain consisting of:
(a) terminal residue: fucose or glucose, and
(b) middle residue: 1,3-linked glucose, 1,4-linked glucose, 1,6-linked and 1,2,6-linked galactose, wherein the 1,2,6-linked galactose residue is attached by the branch chain at 2-O site.

### Claim 6 (depends on 5)

The polysaccharide as claimed in claim 5, wherein the polysaccharide has galactose in main backbone.

### Claim 7 (depends on 1)

The polysaccharide as claimed in claim 1, which is extracted from Antrodia camphorata by water.

### Claim 8 (depends on 7)

The polysaccharide as claimed in claim 7, wherein the Antrodia camphorata is mycelium or fruit body.

### Claim 9

A method for extracting polysaccharide from Antrodia camphorata comprises:
(a) extracting the Antrodia camphorata by water,
(b) collecting the precipitates of the mixture, and
(c) dialyzing the TCA-soluble fraction.

### Claim 10 (depends on 9)

The method as claimed in claim 9, wherein the step (a) is around 60-120° C.

### Claim 11 (depends on 9)

The method as claimed in claim 9, wherein the step (b) is left the mixture around 0-20° C.

### Claim 12 (depends on 9)

The method as claimed in claim 9, wherein the precipitates are treated with trichloroacetic acid (TCA).

### Claim 13

A composition for hepatoprotective effects comprises water extract from Antrodia camphorata.

### Claim 14 (depends on 1, 13)

The composition as claimed in claim 13, wherein the water extract comprises the polysaccharide as claimed in claim 1.

### Claim 15 (depends on 13)

The composition as claimed in claim 13, wherein the hepatoprotective effect is preventing or reducing the hepatocyte necrosis.

### Claim 16 (depends on 14)

The composition as claimed in claim 14, wherein the hepatoprotective effect is preventing or reducing the hepatocyte necrosis.

### Claim 17 (depends on 16)

The composition as claimed in claim 16, wherein the hepatocyte necrosis is reduced via scavenging oxygen free radical formation, increasing IL-2, or decreasing cytotoxic T lymphocyte.

### Claim 18 (depends on 13)

The composition as claimed in claim 13, wherein the hepatoprotective effect is against fulminant hepatitis.

### Claim 19 (depends on 14)

The composition as claimed in claim 14, wherein the hepatoprotective effect is against fulminant hepatitis.

### Claim 20

A method for providing hepatoprotective effect comprises administering a patient with an effective amount of water extract from Antrodia camphorata.

### Claim 21 (depends on 1, 20)

The method as claimed in claim 20 wherein the water extract is the polysaccharide as claimed in claim 1.
